- email:professionalcustserv@informa.com
- phone:+44 (0) 20 7017 5503
 |
The 19th Annual
Biotech & Pharmaceutical Patenting Conference 2011
16 - 17 February 2011
|
Biotech & Pharmaceutical Patenting Conference 2011: Intellectual property filing, IP protection, extension and patent litigation strategies
IBC Legal’s Biotech & Pharmaceutical Patenting 2011 event will help companies understand how to develop patent strategies that maximise the lifecycles of their patents whilst not breaching antitrust laws
Join our leading panel of speakers to discuss pharmaceuticals and biotech regulatory developments and recent case law including (but not limited to) conclusions from:
- Ariad vs Lilly
- Biogen Inc v Medeva Plc
- Actavis UK Limited v Novartis AG
- H. Lundbeck A/S and anor v Alphapharm Pty Ltd and the
- EPO Enlarged Board of Appeal’s decision on G 02/08 ABBOTT RESPIRATORY/Dosage regime
Additionally, hear patent offices from around the world advise on patent filing strategies.
Find out more and benefit from the best prices by downloading the Biotech & Pharmaceutical Patenting event agenda today!
Expert Advisors at Biotech & Pharma Patenting 2011:
Anthony Tridico, Finnegan
Boris Kreye, Bird & Bird
Candi Soames, Edwards Angell Palmer & Dodge
Dr Michael Alt, Bird & Bird
Andrew Bentham, JA Kemp & Co
Joaquim Eugenio Goulart, Dannemann Siemsen Advogados
Tony Maschio, Edwards Angell Palmer & Dodge
Gustavo de Freitas Morais, Dannemann Siemsen Advogados
Ravi Srinivasan, JA Kemp & Co
Expert speakers at the 2011 Biotech & Pharma Patenting Conference:
Click here for the full list of 25 specialised speakers
Perspectives from your colleagues
- Dr Frank Burkert, European Patent Attorney, Bayer HealthCare
- Dr. Michael Kompter, European Patent & Trademark Attorney, Boehringer Ingelheim
- Susan Jones, Head of Corporate Legal Antitrust, Novartis International
- Marc A. Markus, Head of Patents Biotherapeutics East, Pfizer
- André Bourgouin, VP Corporate Intellectual Property, Ipsen Pharma
- Alexandre Mencik, Associate General Counsel, Amgen
- Li Westerlund, Vice President Global IP, Bavarian Nordic
Hear from Regulators
- Dr Roman Maksymiw, Head of Division, German Patent and Trademark Office, DPMA
- Satoshi Moriyasu, Senior Director/Examiner, Medical Science Division, Third Patent Examination Department, Japan Patent Office
- Jutta Hausser, Asian Patent Information Specialist, European Patent Office
- John Ogier, Intellectual Property Registrar, Bailiwick of Guernsey Intellectual Property Office
Insights from Advisors - see the full list of advisors also sharing valuable insights.
Key reasons to attend IBC Legal Conferences' Biotech & Pharmaceutical Patenting 2011 event in Munich
- Analyse the evolving Biotech & Pharmaceutical market landscape and what this means for a holistic patent strategy
- Maximise your chance of successful patent filing for new scientific processes
- Optimise your patent life cycles and extend your market dominance
- Examine landmark appeal and litigation decisions and analyse the implications for future patent cases
- Hear in depth insights on the legal procedures in key European, US, Asian and Brazilian jurisdictions
A small selection of the many companies who have attended Biotech & Pharma Patenting:
Philip Morris Products - BioGeneriX - Transgene - Fujifilm - Clavis Pharma - Merck Serono - Teva Pharmaceutical Industry - Warner Chilcott UK - Oxford Immunotec - Synthon - Intl Patent Bureau - Genepharm - IMS Health - DSM Nutritional Products - Sanofi Pasteur - Astrazeneca R&D - Actelion Pharmaceuticals - Institut Francais Du Petrole - Ivax Pharmaceuticals - F Hoffmann-La Roche - Micromet - Helsinn Healthcare - Fibrogen Inc - United Trademark & Patent Services - Robert Bosch - Philips - Novozymes - Pliva Research Institute - British American Tobacco Investments - Unipath - Merial - Novo Nordisk - Saudi Food & Drug Authority - Bioinvent Intl - Nony & Partners - Howrey - Solvay Pharmaceuticals - Sagem Defense Securite - Novartis Pharma - Zacco Norway - Cambridge Antibody Technology - Norwegian Industrial Property Office - Innate Pharma - Al-Hikma Pharmaceuticals - Pfizer
Sponsored By:
Media Partners:
Feeds | Like | Share    |
Download Latest Information Now
(updated 21 May 2012)
What do your peers think of Biotech & Pharmaceutical Patenting 2011 in Munich?
"All you need to know in biotech and pharma: annual update!"
